{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:07:00Z","timestamp":1789556820879,"version":"build-2803163510"},"reference-count":18,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"unspecified","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chongqing Talents, Leading Talents of Innovation and Entrepreneurship program","award":["CQYC20220303476"],"award-info":[{"award-number":["CQYC20220303476"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the safety and efficacy of transapical epicardial temporary pacemaker lead implantation compared with the conventional transvenous approach in patients undergoing transapical transcatheter aortic valve implantation (TAVI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-centre retrospective study, 399 patients who underwent transapical TAVI between December 2018 and August 2024 were included. Of these, 298 received transapical epicardial temporary pacing leads and 101 received transvenous leads. Primary outcomes included pacemaker-related cardiac tamponade, valve displacement and mortality. Secondary outcomes encompassed perioperative complications, permanent pacemaker implantation and postoperative adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No cases of cardiac tamponade, valve displacement or mortality related to temporary pacing were observed in either group. Poor lead contact occurred in one patient (0.3%) in the transapical group versus three patients (3.0%) in the transvenous group (p=0.05). Postoperative permanent pacemaker implantation was required in 12 transapical patients (4.0%) and three transvenous patients (3.0%, p=0.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Transapical epicardial temporary pacing is a safe and effective alternative to transvenous pacing during transapical TAVI, with comparable complication rates and potential technical benefits. Further randomised studies are warranted to validate these findings and explore long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2025-003960","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:05:19Z","timestamp":1787231119000},"page":"e003960","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Transapical epicardial temporary pacemaker lead implantation in patients with transapical TAVI"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8215-5726","authenticated-orcid":false,"given":"Chunshui","family":"Liang","sequence":"first","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwen","family":"Li","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhou","family":"Feng","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Jian","sequence":"additional","affiliation":[{"name":"Army Medical University Xinqiao Hospital Department of Cardiovascular Surgery, Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026091603502034000_13.2.e003960.1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.amjcard.2019.05.044","article-title":"The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy","volume":"124","author":"Goldsweig","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026091603502034000_13.2.e003960.2","doi-asserted-by":"crossref","unstructured":"Santos-Mart\u00ednez S , Amat-Santos IJ . New Challenging Scenarios in Transcatheter Aortic Valve Implantation: Valve-in-valve, Bicuspid and Native Aortic Regurgitation. Eur Cardiol 2021;16. doi:10.15420\/ecr.2021.12","DOI":"10.15420\/ecr.2021.12"},{"key":"2026091603502034000_13.2.e003960.3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","article-title":"Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study","volume":"403","author":"Vahl","year":"2024","journal-title":"The Lancet"},{"key":"2026091603502034000_13.2.e003960.4","doi-asserted-by":"crossref","unstructured":"Schneeberger Y , Seiffert M , Schaefer A , et al . TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve. Front Cardiovasc Med 2022;8. doi:10.3389\/fcvm.2021.743579","DOI":"10.3389\/fcvm.2021.743579"},{"key":"2026091603502034000_13.2.e003960.5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.athoracsur.2020.10.030","article-title":"Transapical Transcatheter Valve Replacement Using J-Valve for Aortic Valve Diseases","volume":"112","author":"Xue","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2026091603502034000_13.2.e003960.6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.23736\/S0021-9509.22.11260-7","article-title":"Initial experience with repositionable J-Valve for severe aortic regurgitation: a single-center experience","volume":"63","author":"Liu","year":"2022","journal-title":"J Cardiovasc Surg"},{"key":"2026091603502034000_13.2.e003960.7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jcin.2023.05.018","article-title":"Transcatheter Treatment of Native Aortic Valve Regurgitation: The North American Experience With a Novel Device","volume":"16","author":"Santiago","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026091603502034000_13.2.e003960.8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2022.05.035","article-title":"Comparison of left ventricular with right ventricular rapid pacing on tamponade during TAVI","volume":"360","author":"Savvoulidis","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026091603502034000_13.2.e003960.9","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-304708"},{"key":"2026091603502034000_13.2.e003960.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.08.012"},{"key":"2026091603502034000_13.2.e003960.11","doi-asserted-by":"publisher","DOI":"10.2217\/fca.13.43"},{"key":"2026091603502034000_13.2.e003960.12","first-page":"1139","article-title":"A Highly Predictive Risk Model for Pacemaker Implantation After TAVR","volume":"10","author":"Maeno","year":"2017","journal-title":"JACC: Cardiovascular Imaging"},{"key":"2026091603502034000_13.2.e003960.13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020906","article-title":"Predictors of Permanent Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement \u2010 A Systematic Review and Meta\u2010Analysis","volume":"10","author":"Ullah","year":"2021","journal-title":"JAHA"},{"key":"2026091603502034000_13.2.e003960.14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijcard.2023.01.015","article-title":"Reducing cardiac tamponade caused by temporary pacemaker perforation in transcatheter aortic valve replacement","volume":"377","author":"Feldt","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026091603502034000_13.2.e003960.15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12928-020-00676-0","article-title":"A novel technique to avoid perforation of the right ventricle by the temporary pacing lead during transcatheter aortic valve implantation","volume":"36","author":"Tanaka","year":"2021","journal-title":"Cardiovasc Interv and Ther"},{"key":"2026091603502034000_13.2.e003960.16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/jcdd10080341","article-title":"Intracoronary Pacing during \u201cChimney Technique\u201d in Transcatheter Aortic Valve-in-Valve Implantation: An Alternative Temporary Rapid Ventricular Stimulation?","volume":"10","author":"Cafaro","year":"2023","journal-title":"JCDD"},{"key":"2026091603502034000_13.2.e003960.17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.21037\/atm-20-5817","article-title":"Real-time three-dimensional transesophageal echocardiographic guidance versus fluoroscopic guidance for transvenous temporary cardiac pacemaker implantation during transcatheter aortic valve implantation surgeries","volume":"8","author":"Cao","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026091603502034000_13.2.e003960.18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12471-024-01869-5","article-title":"Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trial","volume":"32","author":"Rooijakkers","year":"2024","journal-title":"Neth Heart J"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2025-003960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:50:37Z","timestamp":1789555837000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2025-003960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,20]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/openhrt-2025-003960"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2025-003960","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}